BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2848780)

  • 1. Enhancement of Epstein-Barr virus gene expression by other herpesviruses.
    Kikuta H; Rapp F
    Intervirology; 1988; 29(5):281-91. PubMed ID: 2848780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional complementation between Epstein-Barr virus and herpesvirus papio.
    Prachová K; Roubal J; Agrba VZ; Timanovskaya VV; Voevodin AF
    Intervirology; 1983; 19(1):52-5. PubMed ID: 6298145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
    Cho MS; Gissmann L; Hayward SD
    Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
    Lidin B; Lamon EW
    Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
    J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
    Fujiwara S
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.
    Arcenas R; Widen RH
    BMC Microbiol; 2002 Jul; 2():20. PubMed ID: 12137568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
    Sato H; Takimoto T; Pagano JS; Raab-Traub N
    J Virol; 1988 Sep; 62(9):3288-94. PubMed ID: 2841481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus carried by Raji cells: a mutant in early functions?
    Kallin B; Klein G
    Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
    Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M; Kato C; Kamide M; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids.
    Klein G; Clements G; Zeuthen J; Westman A
    Cancer Lett; 1977 Jul; 3(1-2):91-8. PubMed ID: 196751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.